Differentiated Thyroid Cancer—Treatment: State of the Art

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors

(2017) Ole Ancker et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effects and Role of Multikinase Inhibitors in Thyroid Cancer

(2016) Rasmus Laursen et al.   CURRENT PHARMACEUTICAL DESIGN

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes

(2016) Gustavo C. Penna et al.   CYTOGENETIC AND GENOME RESEARCH

Unknown

(2016) M. Dietlein et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

(2016) Bryan R. Haugen et al.   THYROID

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

(2016) Loredana Lorusso et al.   OncoTargets and Therapy

Selective use of sorafenib in the treatment of thyroid cancer

(2016) Fabián Pitoia et al.   Drug Design Development and Therapy

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience

(2016) R. A. Werner et al.   Scientific Reports

Differenzierte Schilddrüsenkarzinome

(2015) V. Tiedje et al.   INTERNIST

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

(2015) Martin Schlumberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

(2015) Gary L. Francis et al.   THYROID

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

Guidelines for the management of thyroid cancer

(2014) Petros Perros et al.   CLINICAL ENDOCRINOLOGY

Differences in the Recurrence and Mortality Outcomes Rates of Incidental and Nonincidental Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis of 21 329 Person-Years of Follow-up

(2014) Hisham Mehanna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Revisiting the Guidelines Issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: A Gradual Move Towards Consensus Between Japanese and Western Practice in the Management of Thyroid Carcinoma

(2014) Hiroshi Takami et al.   WORLD JOURNAL OF SURGERY

The Clinical and Economic Burden of a Sustained Increase in Thyroid Cancer Incidence

(2013) B. Aschebrook-Kilfoy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging?

(2013) Anca M. Avram et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

(2013) Henning Dralle et al.   LANGENBECKS ARCHIVES OF SURGERY

Molecular Alterations in Partially-Encapsulated or Well-Circumscribed Follicular Variant of Papillary Thyroid Carcinoma

(2013) Brooke E. Howitt et al.   THYROID

The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0

(2012) E. B. Silberstein et al.   JOURNAL OF NUCLEAR MEDICINE

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

(2012) Martin Schlumberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

(2012) Ujjal Mallick et al.   NEW ENGLAND JOURNAL OF MEDICINE

The epidemiology of thyroid disease

(2011) M. P. J. Vanderpump   BRITISH MEDICAL BULLETIN

Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients

(2011) Yasuhiro Ito et al.   ENDOCRINE JOURNAL

Familial thyroid cancer: a review

(2011) Vânia Nosé   MODERN PATHOLOGY

Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma

(2011) Babak Fallahi et al.   NUCLEAR MEDICINE COMMUNICATIONS

Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

(2010) R. Michael Tuttle et al.   THYROID

Thyroid Pathology in PTEN-Hamartoma Tumor Syndrome: Characteristic Findings of a Distinct Entity

(2010) Anna Ray Laury et al.   THYROID

Papillary Thyroid Carcinoma With Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma. A Clinicopathologic, Immunohistochemical, and Molecular Study of Eight Cases

(2009) Sofia Asioli et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

New targets and therapeutic approaches for endocrine malignancies☆

(2009) Martin Fassnacht et al.   PHARMACOLOGY & THERAPEUTICS

Epidemiology of thyroid nodules

(2008) Diana S. Dean et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Early Clinical Studies of Novel Therapies for Thyroid Cancers

(2008) Steven I. Sherman   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

(2008) Anna M. Sawka et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Guidelines for radioiodine therapy of differentiated thyroid cancer

(2008) M. Luster et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING